STRESS PROTEIN 60 DURING MYOCARDIAL ISCHEMIA
心肌缺血期间的应激蛋白 60
基本信息
- 批准号:2211222
- 负责人:
- 金额:$ 10.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-08-01 至 1998-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Coronary artery disease can lead to chronic heart failure, need for
revascularization (by-pass surgery), or life-threatening cardiac
arrhythmias. It is the cause of one and a half million acute myocardial
infarctions per year in the USA, more than half of them lethal. Its cost
is the highest of all Current medical diseases in the nation. Coronary
artery disease affects the blood supply of the heart muscle (myocardium)
and, therefore, decreases oxygen delivery to myocardial cells. The
mitochondria of cardiac myocytes is one of the major targets for ischemia-
induced damage. Limitations of oxygen delivery reduces mitochondrial
oxidative phosphorylation and contributes to the reduction of
intracellular ATP levels. Some investigators have indicated that the
inability of the mitochondria to self-repair following restoration of
blood flow may be one of the crucial events leading to the ultimate death
of myocardial cells. Although it is not clear if sarcolemmal or
mitochondrial damage is the main event in the irreversible damage of the
myocardial cell, the role of mitochondrial changes in decreased myocardial
functions are not questioned. Recent studies have shown that heat shock
protein (HSP) 60, which is a member of the stress protein family and are
thought to have a protective role during oxidative stress, is required for
the assembly of multimeric enzyme complexes within the mitochondria. We
have recently found that during acute occlusion of the descending coronary
artery for 30 minutes in the rat heart, which leads to ischemia in the
left ventricle, there is a marked and specific increase in HSP6O mRNA
level. This finding leads us to believe that HSP6O as other related HSPs
may have a protective role and is probably involved in the repair of the
mitochondrial enzymatic complexes vital for the normal function of the
mitochondria. It is our objective to investigate this ischemia-induced
change in HSP6O expression and determine if HSP60 mediates protection
processes in the mitochondria that contribute to recovery from ischemic
injury in the myocardial cell.
冠状动脉疾病可导致慢性心力衰竭,需要
血运重建(旁路手术)或危及生命的心脏
心律不齐。它是150万急性心肌梗死的原因
在美国,每年有超过一半的脑梗塞是致命的。它的成本
是美国目前所有医学疾病中最高的。冠状动脉
动脉疾病影响心肌(心肌)的血液供应
因此,减少了对心肌细胞的氧气输送。这个
心肌细胞线粒体是心肌缺血的主要靶点之一。
诱导性损害。氧输送的限制减少了线粒体
氧化磷酸化,有助于减少
细胞内三磷酸腺苷水平。一些调查人员表示,
线粒体在修复后不能自我修复
血液流动可能是导致最终死亡的关键事件之一
心肌细胞。尽管目前还不清楚肌膜或
线粒体损伤是心肌细胞不可逆性损伤的主要事件。
心肌细胞线粒体改变在心肌细胞减少中的作用
功能不会受到质疑。最近的研究表明,热休克
蛋白(HSP)60,是应激蛋白家族的成员,是
被认为在氧化应激过程中具有保护作用,是
线粒体内多聚体酶复合体的组装。我们
最近发现,在急性冠状动脉降支闭塞期间
在大鼠心脏中动脉注射30分钟,导致心脏缺血
左心室HSP60mRNA有明显的、特异性的增加
水平。这一发现使我们相信HSP60和其他相关的HSP一样
可能起到保护作用,并可能参与修复
线粒体酶复合体对细胞的正常功能至关重要
线粒体。我们的目标是研究这种由缺血引起的
热休克蛋白60表达的变化及热休克蛋白60是否参与保护
线粒体中有助于脑缺血恢复的过程
心肌细胞的损伤。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(4)
Endothelium-derived relaxing factor contributes to the regulation of endothelial permeability.
内皮源性舒张因子有助于内皮通透性的调节。
- DOI:10.1002/jcp.1041510309
- 发表时间:1992
- 期刊:
- 影响因子:5.6
- 作者:Oliver,JA
- 通讯作者:Oliver,JA
Synthesis of angiotensinogen by renin-containing neuroblastomas.
含肾素的神经母细胞瘤合成血管紧张素原。
- DOI:10.1152/ajpcell.1989.257.2.c185
- 发表时间:1989
- 期刊:
- 影响因子:0
- 作者:Petrossian,G;Oliver,JA
- 通讯作者:Oliver,JA
Changes in luminal flow rate modulate basal and bradykinin-stimulated cell [Ca2+] in aortic endothelium.
管腔流速的变化调节主动脉内皮细胞的基础细胞和缓激肽刺激细胞 [Ca2+]。
- DOI:10.1002/jcp.1041510107
- 发表时间:1992
- 期刊:
- 影响因子:5.6
- 作者:Oliver,JA;ChaseJr,HS
- 通讯作者:ChaseJr,HS
Stable expression of a human HSP70 gene in a rat myogenic cell line confers protection against endotoxin.
人类 HSP70 基因在大鼠生肌细胞系中的稳定表达可提供针对内毒素的保护。
- DOI:10.1152/ajpcell.1996.270.4.c1017
- 发表时间:1996
- 期刊:
- 影响因子:0
- 作者:Chi,SH;Mestril,R
- 通讯作者:Mestril,R
Adenovirus-mediated gene transfer of a heat shock protein 70 (hsp 70i) protects against simulated ischemia.
腺病毒介导的热休克蛋白 70 (hsp 70i) 基因转移可防止模拟缺血。
- DOI:10.1006/jmcc.1996.0228
- 发表时间:1996
- 期刊:
- 影响因子:0
- 作者:Mestril,R;Giordano,FJ;Conde,AG;Dillmann,WH
- 通讯作者:Dillmann,WH
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUBEN MESTRIL其他文献
RUBEN MESTRIL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUBEN MESTRIL', 18)}}的其他基金
MITOCHONDRIAL STRESS PROTEINS AND CARDIOPROTECTION
线粒体应激蛋白和心脏保护
- 批准号:
6390093 - 财政年份:2000
- 资助金额:
$ 10.66万 - 项目类别:
MITOCHONDRIAL STRESS PROTEINS AND CARDIOPROTECTION
线粒体应激蛋白和心脏保护
- 批准号:
6619566 - 财政年份:2000
- 资助金额:
$ 10.66万 - 项目类别:
MITOCHONDRIAL STRESS PROTEINS AND CARDIOPROTECTION
线粒体应激蛋白和心脏保护
- 批准号:
6192642 - 财政年份:2000
- 资助金额:
$ 10.66万 - 项目类别:
MITOCHONDRIAL STRESS PROTEINS AND CARDIOPROTECTION
线粒体应激蛋白和心脏保护
- 批准号:
6527373 - 财政年份:2000
- 资助金额:
$ 10.66万 - 项目类别:
相似海外基金
Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
- 批准号:
22K09003 - 财政年份:2022
- 资助金额:
$ 10.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
- 批准号:
21K07762 - 财政年份:2021
- 资助金额:
$ 10.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
- 批准号:
20K16927 - 财政年份:2020
- 资助金额:
$ 10.66万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
- 批准号:
20H00526 - 财政年份:2020
- 资助金额:
$ 10.66万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
- 批准号:
20K21245 - 财政年份:2020
- 资助金额:
$ 10.66万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
- 批准号:
G0900887/1 - 财政年份:2011
- 资助金额:
$ 10.66万 - 项目类别:
Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
- 批准号:
05558090 - 财政年份:1993
- 资助金额:
$ 10.66万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
- 批准号:
04453031 - 财政年份:1992
- 资助金额:
$ 10.66万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)